Efficacy and safety of metronomic chemotherapy for patients with advanced primary hepatocellular carcinoma with major portal vein tumor thrombosis
Hyun Young Woo, Jun Mo Youn, Si Hyun Bae, Jeong Won Jang, Jung Hoon Cha, Hye Lim Kim, Ho Jong Chun, Byung Gil Choi, Jong Young Choi, Seoung Kew Yoon
Korean J Hepatol. 2012;18(1):32-40. Published online 2012 Mar 22 DOI: https://doi.org/10.3350/kjhep.2012.18.1.32
Citations to this article as recorded by 
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation
Arianna Scagliotti, Laura Capizzi, Marina Elena Cazzaniga, Alice Ilari, Marco De Giorgi, Nicoletta Cordani, Matteo Gallazzi, Antonino Bruno, Giuseppe Pelosi, Adriana Albini, Marialuisa Lavitrano, Emanuela Grassilli, Maria Grazia Cerrito
Frontiers in Oncology.2022;[Epub] CrossRef
Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
Aline Mähringer‐Kunz, Verena Steinle, Christoph Düber, Arndt Weinmann, Sandra Koch, Irene Schmidtmann, Sebastian Schotten, Jan B. Hinrichs, Dirk Graafen, Daniel Pinto dos Santos, Peter R. Galle, Roman Kloeckner
Liver International.2019; 39(2): 324. CrossRef
Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
Cem Simsek, Ece Esin, Suayib Yalcin
Journal of Oncology.2019; 2019: 1. CrossRef
Potentiating cancer vaccine efficacy in liver cancer
Maria Tagliamonte, Annacarmen Petrizzo, Angela Mauriello, Maria Lina Tornesello, Franco M Buonaguro, Luigi Buonaguro
OncoImmunology.2018; 7(10): e1488564. CrossRef
Rationale for the use of metronomic chemotherapy in gastrointestinal cancer
Roberto Filippi, Pasquale Lombardi, Ilaria Depetris, Elisabetta Fenocchio, Virginia Quarà, Giovanna Chilà, Massimo Aglietta, Francesco Leone
Expert Opinion on Pharmacotherapy.2018; 19(13): 1451. CrossRef
Feasibility and Pilot Studies in Palliative Care Research: A Systematic Review
Terry A. Jones, Timothy S. Olds, David C. Currow, Marie T. Williams
Journal of Pain and Symptom Management.2017; 54(1): 139. CrossRef
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clinical and Molecular Hepatology.2017; 23(2): 128. CrossRef
Combinatorial immunotherapy strategies for hepatocellular carcinoma
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, Gennaro Ciliberto, Franco M Buonaguro, Luigi Buonaguro
Current Opinion in Immunology.2016; 39: 103. CrossRef
A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma
Myeong Jun Song, Si Hyun Bae, Ho Jong Chun, Jong Young Choi, Seung Kew Yoon, Jun Young Park, Kwang Hyub Han, Young Seok Kim, Hyung Joon Yim, Soon Ho Um, Woo Jin Chung, Jae Seok Hwang, Sung-Bum Cho, Jong Ryul Eun
Cancer Chemotherapy and Pharmacology.2015; 75(4): 739. CrossRef
Metronomics: towards personalized chemotherapy?
Nicolas André, Manon Carré, Eddy Pasquier
Nature Reviews Clinical Oncology.2014; 11(7): 413. CrossRef
Metronomic Chemotherapy: Possible Clinical Application in Advanced Hepatocellular Carcinoma
Takuji Torimura, Hideki Iwamoto, Toru Nakamura, Hironori Koga, Takato Ueno, Robert S. Kerbel, Michio Sata
Translational Oncology.2013; 6(5): 511. CrossRef